JosephMerrimanMD

PubMed

• 36 citations
  Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.
  James Arthur Kuzman, David D. Stenehjem, Joseph Merriman, Archana M. Agarwal, Shiven B. Patel
  BMC Urology. 2017-01-05
• 3 citations
  Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue
  DonRaphael P. Wynn, Joseph Merriman, Ami B. Patel, Ying J. Hitchcock, Ignacio Garrido-Laguna
  Clinical Neurology and Neurosurgery. 2016-10-01
• 8 citations
  Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma.
  David D. Stenehjem, Andrew W. Hahn, David Gill, Dan Albertson, Banumathy Gowrishankar
  Plos One. 2019-01-25

Journal Articles

• Neutrophil-lypmhocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patient with renal cell carcinoma  
  Kuzman, JA, Stenehjem, DD, Merriman, J, Agarwal, AM, Patel, SB, Hahn, AW, Alex, A, Albertson, D, Gill, DM, Agarwal, N, BMC Urology, 1/1/2017
• Effect of treatment dose reductions in the setting of hand-foot syndrome on survival outcomes in patients with metastatic renal cell carcinoma treated with vascular en...  
  Bailey EB, Merriman J, Maughan B, et al, Journal of Oncology Pharmacy Practice, 1/1/2017
• Extension of overall survival beyond objective responses in patient with metastatic renal cell carcinoma treated with high-dose interleukin-2  
  Stenehjem, DD, Toole, M, Merriman, J, Parikh, K, Daignault, S, Scarlett, S, Esper, P, Skinner, K, Udager, A, Tantravahi, SK, Gill, D, Straubhar, AM, Agarwal, AM, Gross..., Cancer Immunology and Immunotherapy, 1/1/2016
• Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue  
  Wynn, D, Merriman J, Patel, AB, Hitchcock, YJ, Garrido-Laguna, I, Renner, D, Clardy, SL, Clinical Neurology and Neurosurgery, 1/1/2016
• Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma  
  Merriman, J, Tward, J, Albertson, D, Dechet, C, Agarwal, N, Journal of Immunotherapy, 1/1/2016
• Join now to see all

Abstracts/Posters

• Breast cancer risk assessment and chemoprevention use among VA primary care.
  Merriman J, Bidassie B, Kovach A, Vallette M, Park YHA, Aggarwal A, Colonna S, American Society of Clinical Oncology annual meeting, Chicago, IL, 1/1/2017
• Extension of overall survival (OS) beyond objective responses (OR) in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with high dose interleukin-2 (...
  Stenehjem DD, Toole M, Merriman J, Parikh K, Daignuault S, Scarlett S, Esper P, Skinner K, Udager A, Tantravahi SK, Straubhar AM, Agarwal AM, Van Atta J, Samlowski WE,..., American Society of Clinical Oncology annual meeting, Chicago, IL, 1/1/2015
• Correlation of stable disease (SD) as best response with survival outcomes in patients (pts) with clear cell (cc) metastatic renal cell carcinoma (mRCC) treated with h...
  Merriman J, Parikh K, Tantravahi SK, Straubhar AM, Agarwal AM, Sendilnathan A, Van Atta J, Batten JA, Grossmann KF, Samlowski WE, Stenehjem DD, Agarwal N, American Society of Clinical Oncology annual meeting, Chicago, IL, 1/1/2014